regorafenib 40 MG Oral Tablet
- RxCUI
- 1312402
- RxNorm name
- regorafenib 40 MG Oral Tablet
- Display name
- regorafenib 40 MG Oral Tablet
- Full name
- regorafenib 40 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stivarga | REGORAFENIB | Bayer HealthCare Pharmaceuticals Inc. | 824f19c9-0546-4a8a-8d8f-c4055c04f7c7 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 1312402 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 824f19c9-0546-4a8a-8d8f-c4055c04f7c7 | regorafenib 40 MG Oral Tablet | PSN | 36 | These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use Initial U.S. Approval: 2012 | 20260209 |
| 824f19c9-0546-4a8a-8d8f-c4055c04f7c7 | regorafenib 40 MG Oral Tablet | SCD | 36 | These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use Initial U.S. Approval: 2012 | 20260209 |